US87166L2097 - Common Stock
SYNLOGIC INC
NASDAQ:SYBX (10/29/2024, 6:39:03 PM)
1.46
+0.04 (+2.82%)
Synlogic, Inc. engages in the discovery and development of synthetic biotic medicines. The company is headquartered in Cambridge, Massachusetts and currently employs 6 full-time employees. The company went IPO on 2015-09-30. The firm is focused on rare metabolic disorders, with its lead program, labafenogene marselecobac (SYNB1934), studied in Synpheny-3, a global, pivotal Phase 3 study for patients with phenylketonuria (PKU), and SYNB1353, a potential treatment for homocystinuria (HCU). The firm's early-stage pipeline includes product candidates for enteric hyperoxaluria, gout, and cystinuria, and has been fueled by a reproducible, proprietary approach that creates gastrointestinal (GI)-restricted, oral medicines with new enzymatic pathways designed to consume or produce specific biological targets. The company designs, develops and manufactures these drug candidates, which are produced by applying genetic engineering to well-characterized probiotics. The Company’s preclinical work includes additional metabolic disease research.
SYNLOGIC INC
301 Binney St Ste 402
Cambridge MASSACHUSETTS 02142
P: 16174019975
CEO: Aoife Brennan
Employees: 6
Website: https://www.synlogictx.com/
SYBX stock results show that Synlogic beat analyst estimates for earnings per share the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Synlogic (NASDAQ:SYBX) just reported results for the second quarter of 2024.Syn...
WINCHESTER, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform...
Are you a firm believer of "sell in May and go away?" If so, check out the top stocks to sell heading into the summer season.
SYBX stock results show that Synlogic missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Here you can normally see the latest stock twits on SYBX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: